RNA-Seq transcriptome profiling identifies CRISPLD2 as a glucocorticoid responsive gene that modulates cytokine function in airway smooth muscle cells.
Asthma is a chronic inflammatory respiratory disease that affects over 300 million people worldwide. Glucocorticoids are a mainstay therapy for asthma because they exert anti-inflammatory effects in multiple lung tissues, including the airway smooth muscle (ASM). However, the mechanism by which gluc...
Main Authors: | Blanca E Himes, Xiaofeng Jiang, Peter Wagner, Ruoxi Hu, Qiyu Wang, Barbara Klanderman, Reid M Whitaker, Qingling Duan, Jessica Lasky-Su, Christina Nikolos, William Jester, Martin Johnson, Reynold A Panettieri, Kelan G Tantisira, Scott T Weiss, Quan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4057123?pdf=render |
Similar Items
-
Vitamin D Modulates Expression of the Airway Smooth Muscle Transcriptome in Fatal Asthma.
by: Blanca E Himes, et al.
Published: (2015-01-01) -
A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor
by: Xiaofeng Jiang, et al.
Published: (2017-08-01) -
CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin.
by: Tao Wang, et al.
Published: (2013-01-01) -
CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis.
by: Jung-Yoon Yoo, et al.
Published: (2014-01-01) -
Childhood infections and asthma: at the crossroads of the hygiene and Barker hypotheses
by: Weiss Scott T, et al.
Published: (2001-09-01)